Ensysce Biosciences stock surged 58% after launching a strategic review to explore partnerships, licensing deals, or asset sales.

Investing.com -- TuHURA Biosciences Inc (NASDAQ:HURA) shares rose 7.4% Friday after the company announced it regained compliance with Nasdaq’s minimum bid price requirement.

As of Tuesday, February 24, Caribou Biosciences, Inc.’s CRBU share price has surged by 10.16%, which has investors questioning if this is right time to sell.

Lexaria Bioscience (NASDAQ:LEXX) was trading lower after the drug delivery platform announced a sale of 2,666,667 shares, par value $0.001 per share, at $1.50 per share in a registered direct offering ...

Twist Bioscience's growth continues to moderate, in part due to macro headwinds. While Twist's focus on transitioning to profitability in the near-term has significantly reduced cash burn, it has also ...

Cogent Biosciences develops precision therapies for genetically defined diseases, with a pipeline targeting rare oncological ...

Learn more about whether Celldex Therapeutics, Inc. or Twist Bioscience Corporation is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

Analysts are estimating that Harmony Biosciences will report an earnings per share (EPS) of $0.98. Harmony Biosciences bulls ...

The Medical group has plenty of great stocks, but investors should always be looking for companies that are outperforming their peers. Has ANIXA BIOSCIENCES INC (ANIX) been one of those stocks this ...

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest ...

Dare Bioscience regains full rights to its lead contraceptive, Ovaprene, after Bayer's exit. The firm now must secure new partnerships to fund its Phase 3 trial and future market launch.